{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:06:55Z","timestamp":1773292015338,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T00:00:00Z","timestamp":1454976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T00:00:00Z","timestamp":1454976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The soluble factors secreted by mesenchymal stem cells are thought to either support or inhibit tumor growth. Herein, we investigated whether the human lung-derived mesenchymal stem cell-conditioned medium (hlMSC-CM) exerts antitumor activity in malignant pleural mesothelioma cell lines H28, H2052 and Meso4.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>hlMSC-CM was collected from the human lung-derived mesenchymal stem cells. Inhibition of tumor cell growth was based on the reduction of cell viability and inhibition of cell proliferation using the XTT and BrdU assays, respectively. Elimination of tumor spheroids was assessed by the anchorage-independent sphere formation assay. The cytokine profile of hlMSC-CM was determined by a chemiluminescence-based cytokine array.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our data showed that hlMSC-CM contains a broad range of soluble factors which include: cytokines, chemokines, hormones, growth and angiogenic factors, matrix metalloproteinases, metalloproteinase inhibitors and cell\u2013cell mediator proteins. The 48- and 72-hour hlMSC-CM treatments of H28, H2052 and Meso4 cell lines elicited significant decreases in cell viability and inhibited cell proliferation. The 72-hour hlMSC-CM incubation of H28 cells completely eliminated the drug-resistant sphere-forming cells, which is more potent than twice the half maximal inhibitory concentration of cisplatin.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings indicate that the cell-free hlMSC-CM confers in vitro antitumor activities via soluble factors in the tested mesothelioma cells and, hence, may serve as a therapeutic tool to augment the current treatment strategies in malignant pleural mesothelioma.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-016-0282-7","type":"journal-article","created":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T14:04:53Z","timestamp":1455026693000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Human lung-derived mesenchymal stem cell-conditioned medium exerts in vitro antitumor effects in malignant pleural mesothelioma cell lines"],"prefix":"10.1186","volume":"7","author":[{"given":"Lourdes","family":"Cortes-Dericks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurene","family":"Froment","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregor","family":"Kocher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph A.","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,9]]},"reference":[{"key":"282_CR1","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12967-014-0260-8","volume":"12","author":"M Madrigal","year":"2014","unstructured":"Madrigal M, Rao KS, Riordan NH. A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods. J Transl Med. 2014;12:260.","journal-title":"J Transl Med."},{"key":"282_CR2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/cgt.2013.59","volume":"20","author":"JKY Chan","year":"2013","unstructured":"Chan JKY, Lam PYP. Human mesenchymal stem cells and their paracrine factors for the treatment of brain tumors. Cancer Gene Ther. 2013;20:539\u201343.","journal-title":"Cancer Gene Ther."},{"key":"282_CR3","doi-asserted-by":"publisher","first-page":"e107001","DOI":"10.1371\/journal.pone.0107001","volume":"9","author":"I Linero","year":"2014","unstructured":"Linero I, Chaparro O. Paracrine effect of mesenchymal stem cells derived from human adipose tissue in bone regeneration. PLoS One. 2014;9:e107001.","journal-title":"PLoS One."},{"key":"282_CR4","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1038\/bjc.2012.201","volume":"106","author":"JM Houthuijzen","year":"2012","unstructured":"Houthuijzen JM, Daenen LGM, Roodhart JML, Voest EE. The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression. Br J Cancer. 2012;106:1901\u20136.","journal-title":"Br J Cancer."},{"key":"282_CR5","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1084\/jem.20051921","volume":"203","author":"AY Khakoo","year":"2006","unstructured":"Khakoo AY, Pati S, Anderson SA, Reid W, Elshal MF, Rovira II, et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi\u2019s sarcoma. J Exp Med. 2006;203:1235\u201347.","journal-title":"J Exp Med."},{"key":"282_CR6","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1002\/jcb.24073","volume":"113","author":"K Gauthaman","year":"2012","unstructured":"Gauthaman K, Yee FC, Cheyyatraivendran S, Biswas A, Choolani M, Bongso A. Human umbilical cord Wharton\u2019s jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro. J Cell Biochem. 2012;113:2027\u201339.","journal-title":"J Cell Biochem."},{"key":"282_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/abbs\/gmq118","volume":"43","author":"L Li","year":"2011","unstructured":"Li L, Tian H, Chen Z, Yue W, Li S, Li W. Inhibition of lung cancer cell proliferation mediated by human mesenchymal stem cells. Acta Biochim Biophys Sin. 2011;43:143\u20138.","journal-title":"Acta Biochim Biophys Sin."},{"issue":"Suppl 2","key":"282_CR8","first-page":"S238","volume":"6","author":"I Opitz","year":"2014","unstructured":"Opitz I. Management of malignant pleural mesothelioma\u2014The European experience. J Thorac Dis. 2014;6 Suppl 2:S238\u201352.","journal-title":"J Thorac Dis."},{"issue":"Suppl 4","key":"282_CR9","first-page":"S397","volume":"5","author":"K Porpodis","year":"2013","unstructured":"Porpodis K, Zarogoulidis P, Boutsikou E, Papaioannou A, Machairiotis N, et al. Malignant pleural mesothelioma: current and future perspectives. J Thorac Dis. 2013;5(Suppl 4):S397\u2013406.","journal-title":"J Thorac Dis"},{"key":"282_CR10","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/labinvest.2009.73","volume":"89","author":"G Karoubi","year":"2009","unstructured":"Karoubi G, Cortes-Dericks L, Breyer I, Schmid RA, Dutly AE. Identification of mesenchymal stromal cells in human lung parenchyma capable of differentiating into aquaporin 5-expressing cells. Lab Investig J Tech Methods Pathol. 2009;89:1100\u201314.","journal-title":"Lab Investig J Tech Methods Pathol."},{"key":"282_CR11","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/1471-2407-14-304","volume":"14","author":"L Cortes-Dericks","year":"2014","unstructured":"Cortes-Dericks L, Froment L, Boesch R, Schmid RA, Karoubi G. Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity. BMC Cancer. 2014;14:304.","journal-title":"BMC Cancer."},{"key":"282_CR12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315\u20137.","journal-title":"Cytotherapy."},{"key":"282_CR13","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nrm3049","volume":"12","author":"C Nombela-Arrieta","year":"2011","unstructured":"Nombela-Arrieta C, Ritz J, Silberstein LE. The elusive nature and function of mesenchymal stem cells. Nat Rev Mol Cell Biol. 2011;12:126\u201331.","journal-title":"Nat Rev Mol Cell Biol."},{"key":"282_CR14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/cncr.24032","volume":"115","author":"JA Cho","year":"2009","unstructured":"Cho JA, Park H, Kim HK, Lim EH, Seo SW, Choi JS, et al. Hyperthermia-treated mesenchymal stem cells exert antitumor effects on human carcinoma cell line. Cancer. 2009;115:311\u201323.","journal-title":"Cancer."},{"key":"282_CR15","doi-asserted-by":"publisher","first-page":"6051","DOI":"10.1158\/0008-5472.CAN-12-1568","volume":"72","author":"M-L Wang","year":"2012","unstructured":"Wang M-L, Pan C-M, Chiou S-H, Chen W-H, Chang H-Y, Lee OK-S, et al. Oncostatin M modulates the mesenchymal\u2013epithelial transition of lung adenocarcinoma cells by a mesenchymal stem cell-mediated paracrine effect. Cancer Res. 2012;72:6051\u201364.","journal-title":"Cancer Res."},{"key":"282_CR16","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.canlet.2010.04.007","volume":"296","author":"B Sun","year":"2010","unstructured":"Sun B, Yu K-R, Bhandari DR, Jung J-W, Kang S-K, Kang K-S. Human umbilical cord blood mesenchymal stem cell-derived extracellular matrix prohibits metastatic cancer cell MDA-MB-231 proliferation. Cancer Lett. 2010;296:178\u201385.","journal-title":"Cancer Lett."},{"key":"282_CR17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2217\/rme.09.74","volume":"5","author":"PR Baraniak","year":"2010","unstructured":"Baraniak PR, McDevitt TC. Stem cell paracrine actions and tissue regeneration. Regen Med. 2010;5:121\u201343.","journal-title":"Regen Med."},{"key":"282_CR18","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1210\/endo.136.3.7532580","volume":"136","author":"JL Martin","year":"1995","unstructured":"Martin JL, Coverley JA, Pattison ST, Baxter RC. Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol. Endocrinology. 1995;136:1219\u201326.","journal-title":"Endocrinology."},{"key":"282_CR19","doi-asserted-by":"publisher","DOI":"10.4161\/onci.25474","volume":"2","author":"M Li","year":"2013","unstructured":"Li M, Knight DA, Snyder LA, Smyth MJ, Stewart TJ. A role for CCL2 in both tumor progression and immunosurveillance. OncoImmunology. 2013;2, e25474.","journal-title":"OncoImmunology."},{"key":"282_CR20","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/bjc.2013.348","volume":"109","author":"S Kondo","year":"2013","unstructured":"Kondo S, Ueno H, Hosoi H, Hashimoto J, Morizane C, Koizumi F, et al. Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma. Br J Cancer. 2013;109:739\u201346.","journal-title":"Br J Cancer."},{"key":"282_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1515\/hsz-2014-0254","volume":"396","author":"Y Fortenberry","year":"2015","unstructured":"Fortenberry Y. The role of serpins in tumor cell migration. Biol Chem. 2015;396:205\u201313.","journal-title":"Biol Chem."},{"key":"282_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1006\/jsre.2001.6318","volume":"102","author":"M Bloomston","year":"2002","unstructured":"Bloomston M, Shafii A, Zervos EE, Rosemurgy AS. TIMP-1 overexpression in pancreatic cancer attenuates tumor growth, decreases implantation and metastasis, and inhibits angiogenesis. J Surg Res. 2002;102:39\u201344.","journal-title":"J Surg Res."},{"key":"282_CR23","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ctrv.2007.10.005","volume":"34","author":"K Dass","year":"2008","unstructured":"Dass K, Ahmad A, Azmi AS, Sarkar SH, Sarkar FH. Evolving role of uPA\/uPAR system in human cancers. Cancer Treat Rev. 2008;34:122\u201336.","journal-title":"Cancer Treat Rev."},{"key":"282_CR24","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/sj.leu.2404489","volume":"21","author":"R Ramasamy","year":"2007","unstructured":"Ramasamy R, Lam EW-F, Soeiro I, Tisato V, Bonnet D, Dazzi F. Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia. 2007;21:304\u201310.","journal-title":"Leukemia."},{"key":"282_CR25","doi-asserted-by":"publisher","first-page":"7175","DOI":"10.1158\/1078-0432.CCR-09-1938","volume":"15","author":"D Chanda","year":"2009","unstructured":"Chanda D, Isayeva T, Kumar S, Hensel JA, Sawant A, Ramaswamy G, et al. Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in prostate cancer bone metastasis. Clin Cancer Res Off J Am Assoc Cancer Res. 2009;15:7175\u201385.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res."},{"key":"282_CR26","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.yexmp.2003.06.001","volume":"75","author":"LB Ohlsson","year":"2003","unstructured":"Ohlsson LB, Varas L, Kjellman C, Edvardsen K, Lindvall M. Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix. Exp Mol Pathol. 2003;75:248\u201355.","journal-title":"Exp Mol Pathol."},{"key":"282_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.canlet.2009.02.011","volume":"280","author":"R Ayuzawa","year":"2009","unstructured":"Ayuzawa R, Doi C, Rachakatla RS, Pyle MM, Maurya DK, Troyer D, et al. Na\u00efve human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo. Cancer Lett. 2009;280:31\u20137.","journal-title":"Cancer Lett."},{"key":"282_CR28","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s000180050322","volume":"55","author":"GJ Maestroni","year":"1999","unstructured":"Maestroni GJ, Hertens E, Galli P. Factor(s) from nonmacrophage bone marrow stromal cells inhibit Lewis lung carcinoma and B16 melanoma growth in mice. Cell Mol Life Sci CMLS. 1999;55:663\u20137.","journal-title":"Cell Mol Life Sci CMLS."},{"key":"282_CR29","first-page":"95","volume":"9","author":"S Ramdasi","year":"2015","unstructured":"Ramdasi S, Sarang S, Viswanathan C. Potential of mesenchymal stem cell based application in cancer. Int J Hematol-Oncol Stem Cell Res. 2015;9:95\u2013103.","journal-title":"Int J Hematol-Oncol Stem Cell Res."},{"key":"282_CR30","doi-asserted-by":"publisher","first-page":"e3077","DOI":"10.1371\/journal.pone.0003077","volume":"3","author":"V Levina","year":"2008","unstructured":"Levina V, Marrangoni AM, DeMarco R, Gorelik E, Lokshin AE. Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One. 2008;3:e3077.","journal-title":"PLoS One."},{"key":"282_CR31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3892\/ijo.2012.1720","volume":"42","author":"J Liu","year":"2013","unstructured":"Liu J, Ma L, Xu J, Liu C, Zhang J, Liu J, et al. Spheroid body-forming cells in the human gastric cancer cell line MKN-45 possess cancer stem cell properties. Int J Oncol. 2013;42:453\u20139.","journal-title":"Int J Oncol."},{"key":"282_CR32","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3892\/ol.2012.940","volume":"4","author":"W-D Liu","year":"2012","unstructured":"Liu W-D, Zhang T, Wang C-L, Meng H-M, Song Y-W, Zhao Z, et al. Sphere-forming tumor cells possess stem-like properties in human fibrosarcoma primary tumors and cell lines. Oncol Lett. 2012;4:1315\u201320.","journal-title":"Oncol Lett."},{"key":"282_CR33","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s12935-014-0143-3","volume":"14","author":"S Saleem","year":"2014","unstructured":"Saleem S, Jamshed A, Faisal S, Hussain R, Tahseen M, Loya A, et al. Patterns of cancer cell sphere formation in primary cultures of human oral tongue squamous cell carcinoma and neck nodes. Cancer Cell Int. 2014;14:542.","journal-title":"Cancer Cell Int."},{"key":"282_CR34","doi-asserted-by":"publisher","first-page":"901","DOI":"10.7150\/jca.11910","volume":"6","author":"G Zhang","year":"2015","unstructured":"Zhang G, Xiong K, Ma W, Xu W, Zeng H. Initiate tumors with single cell spheres formed in serum-containing medium. J Cancer. 2015;6:901\u201312.","journal-title":"J Cancer."},{"key":"282_CR35","first-page":"6287","volume":"8","author":"F-F Sun","year":"2015","unstructured":"Sun F-F, Hu Y-H, Xiong L-P, Tu X-Y, Zhao J-H, Chen S-S, et al. Enhanced expression of stem cell markers and drug resistance in sphere-forming non-small cell lung cancer cells. Int J Clin Exp Pathol. 2015;8:6287\u2013300.","journal-title":"Int J Clin Exp Pathol."},{"key":"282_CR36","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S1040-8428(00)00086-X","volume":"36","author":"B Desoize","year":"2000","unstructured":"Desoize B, Jardillier J-C. Multicellular resistance: another mechanism for multidrug resistance? Crit Rev Oncol Hematol. 2000;36:193\u2013207.","journal-title":"Crit Rev Oncol Hematol."}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-016-0282-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-016-0282-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-016-0282-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-016-0282-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T06:04:59Z","timestamp":1637042699000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-016-0282-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,9]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["282"],"URL":"https:\/\/doi.org\/10.1186\/s13287-016-0282-7","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,9]]},"assertion":[{"value":"2 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"25"}}